AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇬🇭
BORTEZOMIB in Ghana
5 products registered with FDA Ghana — 4 active, 1 expired
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| BORTEZOMIB POWDER INJECTION | UNKNOWN-b24ee6d0 | — | active | 1 Jun 2028 |
| BORTEZOMIB POWDER INJECTION | UNKNOWN-91cf129c | — | active | 1 Jun 2028 |
| BORTERO INJECTION (Each vial contains: Bortezomib 3.5mg) | UNKNOWN-546d9065 | — | active | 1 Oct 2026 |
| BORTERO INJECTION (Each vial contains: Bortezomib 3.5mg) | UNKNOWN-840578a2 | — | expired | 1 Oct 2026 |
| BORTERO INJECTION (Each vial contains: Bortezomib 3.5mg) | UNKNOWN-06297821 | — | active | 1 Oct 2026 |
BORTEZOMIB — FDA Ghana Registration Details
FDA Ghana (Ghana) has 5 registered products containing BORTEZOMIB, of which 4 are currently active. Data is sourced directly from the official FDA Ghana drug register and refreshed daily.
Track BORTEZOMIB registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.